BiotechTubeBiotechTube
Home/Vera Therapeutics/Jonathan Barratt, Ph.D., FRCP
JB

Jonathan Barratt, Ph.D., FRCP

Scientific Advisory Board Member

Vera Therapeutics

Therapeutic Areas

NephrologyImmunologyAutoimmune Diseases

Vera Therapeutics Pipeline

DrugIndicationPhase
AtaciceptIgA Nephropathy (IgAN)Phase 2b/3
MAU868BK Virus Infection in Kidney TransplantPhase 2

Leadership Team at Vera Therapeutics

MF
Marshall Fordyce, M.D.
Founder, President and Chief Executive Officer
SG
Sean Grant
Chief Financial Officer
CL
Celia Lin, M.D.
Chief Medical Officer
JB
Joshua Bruner, J.D.
Chief Business Officer and General Counsel
MF
Mary Fisher
Chief Development Officer
AW
Allison Wey, Ph.D.
Senior Vice President, Regulatory Affairs
RA
Robert Azelby
Board Member
KB
Katherine Bowdish, Ph.D.
Board Member
JC
John Carroll
Board Member
TG
Thomas G. Wiggans
Board Member
View full Vera Therapeutics profile